News

Interim FDG-PET 'Not Justified' in Diffuse Large B-Cell Lymphoma


 

FROM THE ANNUAL CONGRESS OF THE EUROPEAN HEMATOLOGY ASSOCIATION

Dr. Cox and Dr. Pettitt stated that they had no relevant financial disclosures.

Pages

Recommended Reading

NCCN Upgrades Rituximab Regimens for Follicular Lymphoma
B-Cell Lymphoma ICYMI
Chemo Length May Not Affect Survival in Some B-cell Lymphomas
B-Cell Lymphoma ICYMI
Fostamatinib successfully targets the B-cell receptor
B-Cell Lymphoma ICYMI